Evidence map›Paper›PMID 38187006›Full record

ArticleLancet regional health. Americas2024

Clinical and molecular characterization of children and adults with respiratory bocavirus infection in Mexico: a cross-sectional nested study within the ILI002 prospective observational study.

Ana Estela Gamiño-Arroyo, José Arellano-Galindo, Paola Del Carmen Guerra-de-Blas, Ana M Ortega-Villa, Allyson Mateja, Beatriz Llamosas-Gallardo, Ana A Ortíz-Hernández, Rafael Valdéz-Vázquez, Alejandra Ramírez-Venegas, Arturo Galindo-Fraga and 13 more

Open access · goldAbstract read
In one paragraph

Article in Lancet regional health. Americas, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 2 countries.

Ana Estela Gamiño-ArroyoHospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City, Mexico.
José Arellano-GalindoHospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City, Mexico.
Paola Del Carmen Guerra-de-BlasThe Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico.
Ana M Ortega-VillaNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Allyson MatejaClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick County, MD, USA.
Beatriz Llamosas-GallardoInstituto Nacional de Pediatría, Mexico City, Mexico.
Ana A Ortíz-HernándezInstituto Nacional de Pediatría, Mexico City, Mexico.
Rafael Valdéz-VázquezHospital General "Dr. Manuel Gea González", Mexico City, Mexico.
Alejandra Ramírez-VenegasInstituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City, Mexico.
Arturo Galindo-FragaDepartamento de Epidemiología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Ma Lourdes GuerreroDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Pilar Ramos-CervantesDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Luis Mendoza-GarcésThe Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico.
Mónica González-MatusHospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City, Mexico.
Carmen Marroquín-RojasHospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City, Mexico.
Juan Xicohtencatl-CortesHospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City, Mexico.
Sara A OchoaHospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City, Mexico.
Ariadna Cruz-CórdovaHospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City, Mexico.
John H PowersClinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick County, MD, USA.
Guillermo Miguel Ruiz-PalaciosDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
John BeigelNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Sarbelio Moreno-EspinosaHospital Infantil de México Federico Gómez, Instituto Nacional de Salud, Mexico City, Mexico.
Mexican Emerging Infectious Diseases Clinical Research Network (LaRed)
Hospital Infantil de México Federico Gómez · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXFrederick National Laboratory for Cancer Research · USInstituto Nacional de Pediatria · MXNational Institute of Allergy and Infectious Diseases · USHospital General Dr. Manuel Gea Gonzalez · MXInstituto Nacional de Enfermedades Respiratorias · MX

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI PENDLETON, RICHARD · 2019 to 2025
$3932.6M
NCI NIH HHS 75N91019D00024NIAID NIH HHS HHSN272200900001CNIAID NIH HHS HHSN272200900031C
6 · The paper itself

Abstract

Background: Human Bocaviruses (HBoV) can cause acute respiratory tract infections. High coinfection rates cloud its pathogenicity. This study sought to describe the clinical features of HBoV1 disease in children and adults with Influenza-like illness (ILI), exploring associations between viral load, clinical features, and seasonality. Methods: Patients who tested positive for HBoV1 by polymerase chain reaction, enrolled from April 2010 to March 2014 in the ILI002 prospective observational cohort study were included in this cross-sectional nested study. Participants were included in ILI002 if they presented with signs and/or symptoms suggestive of influenza-like illness. Samples were tested for viral load, and NP1 and VP1/VP2 phylogenetic analyses, except for the samples lacking suitable and viable clinical material for genotyping. Findings: We identified HBoV1 in 157 (2.8%) of participants. Prevalence was 4.5% in children and 1.8% in adults. Single HBoV1 detection occurred in 41.1% and 46.3% of children and adults, respectively. Children commonly experienced fever (83.3%), cough with sputum (74.4%), and shortness of breath (72.2%). In the multivariate analysis of children, significant positive associations were detected between viral loads and age (0.20 [95% CI: 0.07, 0.33]), and the presence of fever (2.64 [95% CI: 1.35, 3.94]), nasal congestion (1.03 [95% CI: 0.07, 1.99]), dry cough (1.32 [95% CI: 0.42, 2.22]), chest congestion (1.57 [95% CI: 0.33, 2.80]), red eyes (1.25 [95% CI: 0.35, 2.14]), cough with sputum (1.79 [95% CI: 0.80, 2.78]), and other signs and symptoms such as chills, dizziness, and diaphoresis (1.73 [95% CI: 0.19, 3.27]). In contrast, significant negative associations were found between viral loads and percent neutrophils on the blood count (-0.04 [95% CI: -0.06, -0.02]), fatigue (-1.60 [95% CI: -2.46, -0.74]) and the presence of other symptoms or signs, including adenopathy and rash (-1.26 [95% CI: -2.31, -0.21]). Adults commonly experienced sore throat (73.1%), fatigue (77.4%), and headache (73.1%). In the multivariate analysis of adults, significant positive associations were detected between viral load and body mass index (0.13 [95% CI: 0.04, 0.21]), and the presence of confusion (1.54 [95% CI: 0.55, 2.53]), and sore throat (1.03 [95% CI: 0.20, 1.85]), and significant negative associations were detected between viral load and chest congestion (-1.16 [95% CI: -2.07, -0.24]). HBoV1 was detected throughout the year irrespective of season, temperature, and humidity. Interpretation: This study demonstrated the importance of detecting HBoV1 in patients with influenza-like illness either as single infection or co-infection, in both adults and children, and improves the characterization of HBoV1 seasonality, clinical features, and viral load. Phylogenetic analyses show a high conservation. Funding: The Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), CONACYT (Fondo Sectorial SSA/IMSS/ISSSTE, Projects No. 71260 and No. 127088), Fondos federales no. HIM/2015/006, NIAID, NIH through a contract with Westat, Inc. (HHSN2722009000031, HHSN27200002), NCI, NIH (75N91019D00024, 75N91019F00130). Additional information at the end of the manuscript.

Indexed as

Human bocavirus (HBoV)Influenza-like illness (ILI)Phylogenetic analysisSeasonalityViral load

Identifiers

PMID38187006
PMCPMC10770596
OpenAlexW4389841838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.